<DOC>
	<DOCNO>NCT00005881</DOCNO>
	<brief_summary>RATIONALE : Questionnaires measure quality life may improve ability plan treatment child cancer . PURPOSE : This randomized clinical trial study quality life child treat cancer .</brief_summary>
	<brief_title>Quality Life Children Treated Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess validity reliability quality life questionnaire ( MM-QOL ) develop patient previously currently treat childhood cancer . OUTLINE : This randomize , multicenter study . Patients stratify accord age ( 8-12 v 13-20 ) treatment ( current vs previous ) . Patients randomize one two arm study . Arm I ( Reliability ) : Patients complete questionnaire two week apart . ( age 13-20 stratum close 7/14/00 ) Arm II ( Validity ) : Patients complete study questionnaire plus Child Health Questionnaire . Patients age 8-12 interviewed patient age 13-20 complete write questionnaire . PROJECTED ACCRUAL : A total 716 patient ( 416 arm I ( 208 8-12 age group 208 13-20 age group ) 300 arm II ( 150 8-12 age group 150 13-20 age group ) ) accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Prior current diagnosis pediatric cancer Current chemoradiotherapy ( least 2 month since start therapy ) OR At least 1 year since prior treatment remission PATIENT CHARACTERISTICS : Age : 8 20 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>childhood Burkitt lymphoma</keyword>
	<keyword>stage I childhood lymphoblastic lymphoma</keyword>
	<keyword>stage II childhood lymphoblastic lymphoma</keyword>
	<keyword>stage III childhood lymphoblastic lymphoma</keyword>
	<keyword>stage IV childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>childhood diffuse large cell lymphoma</keyword>
	<keyword>childhood immunoblastic large cell lymphoma</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage III childhood Hodgkin lymphoma</keyword>
	<keyword>stage IV childhood Hodgkin lymphoma</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>stage I childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage I childhood large cell lymphoma</keyword>
	<keyword>stage II childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage II childhood large cell lymphoma</keyword>
	<keyword>stage III childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage III childhood large cell lymphoma</keyword>
	<keyword>stage IV childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage IV childhood large cell lymphoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
</DOC>